Oncogenic PI3K and its role in cancer
- PMID: 16357568
- DOI: 10.1097/01.cco.0000198021.99347.b9
Oncogenic PI3K and its role in cancer
Abstract
Purpose of review: The purpose of this review is to examine the contribution of the PI3K signaling pathway to the development of human tumors and to propose further studies to elucidate how to develop therapeutics for patients with mutations in this pathway.
Recent findings: More than 30% of various solid tumor types were recently found to contain mutations in PIK3CA, the catalytic subunit of PI3K. Further analysis of key genes in this pathway identified an additional eight genes altered in tumors. These were generally found to be mutated in a mutually exclusive manner, thus increasing the mutation frequency of the pathway to 40% in colorectal cancers and emphasizing the importance of the PI3K pathway in tumorigenesis. Functional analyses of PIK3CA mutations revealed that they increase its enzymatic activity, stimulate AKT signaling, allow growth factor-independent growth as well as increasing cell invasion and metastasis.
Summary: The PI3K signaling pathway is dysregulated by a variety of mechanisms in a large fraction of human tumors. Both mutational and functional analyses have shown that PIK3CA is an oncogene that plays an important role in tumor progression. Mutant members of the PI3K pathway, including PIK3CA, are good targets for therapeutic intervention because most of them are kinases, making them attractive for drug development. Gaining further insights into PIK3CA oncogenic mechanisms may produce new biomarkers and help the development of targeted therapeutics.
Similar articles
-
PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation.Cancer Res. 2008 Oct 1;68(19):8127-36. doi: 10.1158/0008-5472.CAN-08-0755. Cancer Res. 2008. PMID: 18829572
-
Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.Cancer. 2018 Sep 15;124(18):3693-3705. doi: 10.1002/cncr.31600. Epub 2018 Oct 5. Cancer. 2018. PMID: 30289966 Free PMC article.
-
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).Int J Oncol. 2012 Mar;40(3):639-44. doi: 10.3892/ijo.2011.1312. Epub 2011 Dec 20. Int J Oncol. 2012. PMID: 22200790 Review.
-
Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.PLoS One. 2017 Jun 29;12(6):e0178865. doi: 10.1371/journal.pone.0178865. eCollection 2017. PLoS One. 2017. PMID: 28662101 Free PMC article.
-
PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches.Cell Cycle. 2009 May 1;8(9):1352-8. doi: 10.4161/cc.8.9.8255. Epub 2009 May 23. Cell Cycle. 2009. PMID: 19305151 Free PMC article. Review.
Cited by
-
DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children's Oncology Group.Clin Cancer Res. 2025 Mar 3;31(5):890-898. doi: 10.1158/1078-0432.CCR-23-2073. Clin Cancer Res. 2025. PMID: 38197878
-
Molecular pathology in breast disease: diagnostic, prognostic, and therapeutic tools.Virchows Arch. 2024 Feb;484(2):247-261. doi: 10.1007/s00428-023-03709-0. Epub 2023 Nov 28. Virchows Arch. 2024. PMID: 38015260 Free PMC article. Review.
-
Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3Kα.Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2215621119. doi: 10.1073/pnas.2215621119. Epub 2022 Nov 7. Proc Natl Acad Sci U S A. 2022. PMID: 36343266 Free PMC article.
-
Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas.Braz J Med Biol Res. 2012 Sep;45(9):851-5. doi: 10.1590/s0100-879x2012007500115. Epub 2012 Jul 12. Braz J Med Biol Res. 2012. PMID: 22782554 Free PMC article.
-
Molecular and genetic properties of tumors associated with local immune cytolytic activity.Cell. 2015 Jan 15;160(1-2):48-61. doi: 10.1016/j.cell.2014.12.033. Cell. 2015. PMID: 25594174 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous